These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11672517)

  • 1. Expression of pyrimidine 5'-nucleotidase subclass I during erythrocyte maturation in rats.
    Hokari S; Miyazaki T; Matsunaga T; Koyama I; Hasegawa M; Komoda T
    J Hematother Stem Cell Res; 2001 Oct; 10(5):703-7. PubMed ID: 11672517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chicken erythrocyte pyrimidine 5'-nucleotidase: purification and characterization of the subclass I enzyme.
    Hokari S; Miyazaki T; Hasegawa M; Koyama L; Komoda T
    Biol Chem; 2001 Jun; 382(6):919-24. PubMed ID: 11501756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced activity of pyrimidine 5'-nucleotidase in rat red blood cells during erythropoiesis.
    Hokari S; Miyazaki T; Hasegawa M; Komoda T
    Biol Chem; 1998 Mar; 379(3):329-33. PubMed ID: 9563829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabbit liver dCMP phosphohydrolase: a pyrimidine 5'-nucleotidase I-like enzyme in non-erythrocytic cells.
    Hokari S; Miyazaki T; Matsunaga T; Kawai S; Koyama I; Komoda T
    Comp Biochem Physiol B Biochem Mol Biol; 2003 Feb; 134(2):381-8. PubMed ID: 12568814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrimidine nucleoside monophosphate kinase hyperactivity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
    Lachant NA; Zerez CR; Tanaka KR
    Br J Haematol; 1987 May; 66(1):91-6. PubMed ID: 3036196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythroid pyrimidine 5'-nucleotidase: cloning, developmental expression, and regulation by cAMP and in vivo hypoxia.
    Mass M; Simo E; Dragon S
    Blood; 2003 Dec; 102(12):4198-205. PubMed ID: 12907448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between reticulocyte count and characteristics of erythrocyte 5'-nucleotidase in dogs, cats, cattle and humans.
    Hossain MA; Yamato O; Yamasaki M; Otsuka Y; Maede Y
    J Vet Med Sci; 2003 Feb; 65(2):193-7. PubMed ID: 12655113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isozymes of human erythrocyte pyrimidine 5'-nucleotidase--chromatographic separation and their properties.
    Hirono A; Fujii H; Miwa S
    Jpn J Exp Med; 1985 Feb; 55(1):37-44. PubMed ID: 2993713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte pyrimidine 5'-nucleotidase inhibition by acute lead exposure in neonatal rats.
    Konantakieti C; Beuthin FC; Louis-Ferdinand RT
    J Biochem Toxicol; 1986 Sep; 1(3):51-9. PubMed ID: 2856073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatographic analysis of human erythrocyte pyrimidine 5'-nucleotidase from five patients with pyrimidine 5'-nucleotidase deficiency.
    Hirono A; Fujii H; Natori H; Kurokawa I; Miwa S
    Br J Haematol; 1987 Jan; 65(1):35-41. PubMed ID: 3028466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte pyrimidine 5'-nucleotidase and deoxynucleotidase isozymes: metallosensitivity and kinetics.
    Cook L; Kubitschek C; Stohs S; Angle C
    Drug Chem Toxicol; 1988 Jun; 11(2):195-213. PubMed ID: 2841083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro and in vivo effects of lead on delta-aminolevulinic acid dehydratase and pyrimidine 5'-nucleotidase.
    Ong CN; Kong YM; Ong HY; Teramoto K
    Pharmacol Toxicol; 1990 Jan; 66(1):23-6. PubMed ID: 2308903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low level lead and inhibition of erythrocyte pyrimidine nucleotidase.
    Angle CR; McIntire MS
    Environ Res; 1978 Oct; 17(2):296-302. PubMed ID: 233817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte arginase, pyrimidine 5'-nucleotidase (P5N), and deoxypyrimidine 5'-nucleotidase (dP5N) as indices of lead exposure.
    Cook LR; Angle CR; Stohs SJ
    Br J Ind Med; 1986 Jun; 43(6):387-90. PubMed ID: 3013277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPLC analysis of erythrocyte pyrimidine-5'-nucleotidase inhibition by lead.
    Rocco RM; Smart JL; Brown DR; Blumberg JB
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):127-36. PubMed ID: 6273981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of Japanese variants of pyrimidine 5'-nucleotidase deficiency.
    Kanno H; Takizawa T; Miwa S; Fujii H
    Br J Haematol; 2004 Jul; 126(2):265-71. PubMed ID: 15238149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on erythrocyte pyrimidine 5'-nucleotidase (P5N) test and its evaluation in workers occupationally exposed to lead.
    Ichiba M; Tomokuni K
    Int Arch Occup Environ Health; 1990; 62(4):305-10. PubMed ID: 2379961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro effect of 13 metals on the activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).
    Oishi H; Ichiba M; Tomokuni K
    J Toxicol Sci; 1994 Nov; 19(4):197-201. PubMed ID: 7884830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of pyrimidine 5'-nucleotidase in human leukocytes.
    de Korte D; van Doorn CC; Sijstermans JM; van Gennip AH; Roos D
    J Inherit Metab Dis; 1989; 12(3):267-72. PubMed ID: 2559246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of pyrimidine 5'-nucleotidase (P5N) activity in whole blood as an index of lead exposure.
    Sakai T; Araki T; Ushio K
    Br J Ind Med; 1988 Jun; 45(6):420-5. PubMed ID: 2840110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.